Welcome to Omeros.com - Omeros – Next-generation Therapeutics Transforming Patient Care

omeros.com

Description: Omeros. Omeros is breaking the mold in the pharmaceutical industry through novel discovery, strategic translational research, and vigorous...

Google PR 4

Trustworthiness Unknown
Avg. Daily Visitors 336

Child Safety Unknown
Avg. Daily Pageviews 3 028

Privacy Unknown

Omeros – Next-generation Therapeutics Transforming Patient Care

Omeros.com: get to the top rated Omeros pages and content popular with USA-based Omeros.com users or check the following digest to find out more. Omeros.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Omeros team are just starting to conquer the social media and they have already achieved a promising result — 52 user activities so far (LinkedIn dominates with around 98% of all user reactions). Omeros.com is hosted with Amazon Data Services NoVa in United States. Omeros traffic is estimated at around 10.1K visits per month.

Visit omeros.com

Domain info

Location:	United States
Registrant:	Registration Private (Domains By Proxy, LLC)
Hosted by:	Amazon Data Services NoVa
Registrar:	GoDaddy.com, LLC
Subnetworks:	44.199.127.36

Alexa's Traffic Estimates & Trends

Traffic Rank:	703 146
Month Average Daily Reach:	0.000009	-32.6%
Month Average Daily Pageviews:	0.000001	+ 283.5%

More details from Alexa

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: 51
Pinterest pins: -
StumbleUpon views: 1

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Omeros.com popular pages to visit

Omeros G Protein-Coupled Receptors (GPCRs) G protein-coupled receptors, or GPCRs, comprise one of the largest families of proteins in the genomes of multicellular organisms. It is estimated that there are...

Omeros – Next-generation Therapeutics Transforming Patient Care Omeros is breaking the mold in the pharmaceutical industry through novel discovery, strategic translational research, and vigorous clinical programs.

Omeros Omeros is one of the first companies to recognize that, in a wide range of pathologic conditions, a combination of agents acting on multiple molecular targets is required for optimal therapeutic effec...